Literature DB >> 3354996

Hypoxemia during sleep in Duchenne muscular dystrophy.

P E Smith1, P M Calverley, R H Edwards.   

Abstract

Overnight polysomnography after acclimatization was performed on 14 patients with Duchenne muscular dystrophy (mean age, 18.3 yr; mean VC, 1.24 L). Despite their lack of sleep-related symptoms and normal daytime blood gas tensions, periods of hypopnea and/or apnea (H/A) were observed in all patients (mean frequency 9.6/h; range, 3.7 to 17.0; mean duration 23.1; range of means, 16 to 36 s). In 9 patients, between 0.5 and 12.3 oxygen desaturations of greater than 5% occurred per hour, with falls from a mean SaO2 baseline of 95.4 +/- 0.6% (SEM) to a mean nadir of 74.2 +/- 3.9% (range, 58 to 90). This desaturating group (n = 9) showed longer and more frequent H/A than did the 5 nondesaturators; the proportion of REM sleep occupied by H/A was 37.7 +/- 3.8% in the desaturating group compared with only 15.1 +/- 5.1% in the remainder (p less than 0.01). The severity of sleep-disordered breathing could not be reliably predicted from daytime pulmonary function test results, and only maximal static expiratory pressure appeared significantly lower in the desaturating group. Hypopneas were associated with reduced chest wall movement in all subjects, and with chest wall paradox in one; continued submental "inspiratory" EMG activity throughout "central" apneas in 2 subjects suggested that these episodes were not truly central in origin. Sleep hypoxemia is imputed in the progression of several chronic respiratory diseases, and its prevention in Duchenne and related neuromuscular diseases may influence morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354996     DOI: 10.1164/ajrccm/137.4.884

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  42 in total

1.  Disorders of Sleep and Breathing during Sleep in Neuromuscular Disease.

Authors:  Erik Van Lunteren; Henry J. Kaminski
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

2.  Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases.

Authors:  Raanan Arens; Hiren Muzumdar
Journal:  Paediatr Respir Rev       Date:  2010-03       Impact factor: 2.726

3.  Nocturnal sleep and oxygen balance in Duchenne muscular dystrophy. A clinical and polygraphic 2-year follow-up study.

Authors:  R Manni; C Zucca; C A Galimberti; A Ottolini; I Cerveri; C Bruschi; M C Zoia; G Lanzi; A Tartara
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

Review 5.  Assessment of respiratory muscle function and strength.

Authors:  N Syabbalo
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

6.  The sleep characteristics in symptomatic patients with Duchenne muscular dystrophy.

Authors:  Karen Tieme Nozoe; Gustavo Antônio Moreira; José Rodolfo Corradini Tolino; Márcia Pradella-Hallinan; Sergio Tufik; Monica Levy Andersen
Journal:  Sleep Breath       Date:  2015-01-08       Impact factor: 2.816

7.  Mechanical ventilation at home.

Authors:  M A Branthwaite
Journal:  BMJ       Date:  1989-05-27

8.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Chronic hypoxia impairs muscle function in the Drosophila model of Duchenne's muscular dystrophy (DMD).

Authors:  Matias Mosqueira; Gabriel Willmann; Hannele Ruohola-Baker; Tejvir S Khurana
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

Review 10.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.